Erste Asset Management Gmb H Moon Lake Immunotherapeutics Transaction History
Erste Asset Management Gmb H
- $11.9 Trillion
- Q2 2025
A detailed history of Erste Asset Management Gmb H transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Erste Asset Management Gmb H holds 15,000 shares of MLTX stock, worth $139,200. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,000
Previous 15,000
-0.0%
Holding current value
$139,200
Previous $598 Million
19.22%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding MLTX
# of Institutions
157Shares Held
54.6MCall Options Held
799KPut Options Held
661K-
Bvf Inc San Francisco, CA19.8MShares$183 Million36.63% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$78.8 Million40.43% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.15MShares$38.5 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.61MShares$24.3 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.67MShares$15.5 Million0.01% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $343M
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...